Quarterly report pursuant to Section 13 or 15(d)

Note 14 - Commitment and Contingencies (Details)

v3.8.0.1
Note 14 - Commitment and Contingencies (Details)
3 Months Ended 9 Months Ended 12 Months Ended
Jan. 05, 2018
USD ($)
Nov. 30, 2017
USD ($)
shares
Oct. 09, 2017
USD ($)
Aug. 23, 2017
USD ($)
Mar. 01, 2017
USD ($)
Jul. 20, 2016
USD ($)
Aug. 01, 2015
USD ($)
Apr. 17, 2015
ft²
Oct. 01, 2014
USD ($)
Feb. 28, 2018
USD ($)
Feb. 28, 2017
USD ($)
Feb. 28, 2018
USD ($)
Feb. 28, 2017
USD ($)
May 31, 2016
USD ($)
shares
May 31, 2017
USD ($)
Note 14 - Commitment and Contingencies (Details) [Line Items]                              
Loss Contingency Accrual, Provision                       $ 10,000      
Debt Conversion, Original Debt, Amount                     $ 100,000 112,500 $ 250,000    
Employee-related Liabilities, Current                   $ 40,562   40,562     $ 34,987
Allocated Share-based Compensation Expense                       55,000 $ 0    
Chief Executive Officer [Member]                              
Note 14 - Commitment and Contingencies (Details) [Line Items]                              
Employment Agreement, Term                 5 years            
Officers' Compensation                 $ 150,000         $ 150,000  
Deferred Compensation Arrangement with Individual, Description                 performance bonus equal to 2% of CLS Labs’ annual EBITDA, up to a maximum annual cash compensation of $1 million (including his base salary)            
Share-based Compensation Arrangement by Share-based Payment Award, Description                 annual stock options, exercisable at the fair market value of CLS Labs’ common stock on the date of grant, in an amount equal to 2% of its annual EBITDA up to $42.5 million and 4% of its annual EBITDA in excess of $42.5 million            
Employee-related Liabilities, Current                   37,500   37,500     37,500
Chief Executive Officer [Member] | Convertible Debt [Member] | Unpaid Accrued Salary Converted to Convertible Note [Member]                              
Note 14 - Commitment and Contingencies (Details) [Line Items]                              
Debt Conversion, Original Debt, Amount $ 37,500   $ 39,521 $ 62,500 $ 112,500 $ 250,000       37,500   112,500      
Chief Operating Officer [Member]                              
Note 14 - Commitment and Contingencies (Details) [Line Items]                              
Employment Agreement, Term             5 years                
Officers' Compensation             $ 150,000                
Deferred Compensation Arrangement with Individual, Description             performance bonus equal to 2% of the Company’s annual EBITDA, up to a maximum annual cash compensation of $1 million (including his base salary)                
Share-based Compensation Arrangement by Share-based Payment Award, Description             annual stock options, exercisable at the fair market value of the Company’s common stock on the date of grant, in an amount equal to 2% of its annual EBITDA up to $42.5 million and 4% of its annual EBITDA in excess of $42.5 million                
Employee-related Liabilities, Current                   37,500   37,500     0
Chief Operating Officer [Member] | One Time Signing Bonus [Member]                              
Note 14 - Commitment and Contingencies (Details) [Line Items]                              
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in Shares) | shares                           250,000  
Allocated Share-based Compensation Expense                           $ 327,500  
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period                           1 year  
President and Chief Financial Officer [Member]                              
Note 14 - Commitment and Contingencies (Details) [Line Items]                              
Officers' Compensation   $ 175,000                          
Deferred Compensation Arrangement with Individual, Description   performance bonus equal to 2% of the Company’s annual EBITDA, and annual restricted stock awards of the Company’s common stock in an amount equal to 3% of its annual EBITDA                          
Share-based Compensation Arrangement by Share-based Payment Award, Description   annual restricted stock awards of the Company’s common stock in an amount equal to 3% of its annual EBITDA                          
President and Chief Financial Officer [Member] | One Time Signing Bonus [Member]                              
Note 14 - Commitment and Contingencies (Details) [Line Items]                              
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in Shares) | shares   500,000                          
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period   1 year                          
Former Officer [Member]                              
Note 14 - Commitment and Contingencies (Details) [Line Items]                              
Employee-related Liabilities, Current                   $ 16,250   16,250     $ 16,250
Building [Member]                              
Note 14 - Commitment and Contingencies (Details) [Line Items]                              
Area of Real Estate Property (in Square Feet) | ft²               14,392              
Lessee, Operating Lease, Term of Contract               72 months              
Lessee, Operating Lease, Renewal Term               10 years              
Deposits [Member]                              
Note 14 - Commitment and Contingencies (Details) [Line Items]                              
Loss Contingency Accrual, Provision                       50,000      
Rent Expense [Member]                              
Note 14 - Commitment and Contingencies (Details) [Line Items]                              
Loss Contingency Accrual, Provision                       15,699      
Remaining Amounts Due Under Lease [Member]                              
Note 14 - Commitment and Contingencies (Details) [Line Items]                              
Loss Contingency Accrual, Provision                       $ 30,000